Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 20 06 2020
accepted: 22 10 2020
entrez: 5 11 2020
pubmed: 6 11 2020
medline: 24 11 2020
Statut: epublish

Résumé

Older people have been reported to be at higher risk of COVID-19 mortality. This study explored the factors mediating this association and whether older age was associated with increased mortality risk in the absence of other risk factors. In UK Biobank, a population cohort study, baseline data were linked to COVID-19 deaths. Poisson regression was used to study the association between current age and COVID-19 mortality. Among eligible participants, 438 (0.09%) died of COVID-19. Current age was associated exponentially with COVID-19 mortality. Overall, participants aged ≥75 years were at 13-fold (95% CI 9.13-17.85) mortality risk compared with those <65 years. Low forced expiratory volume in 1 second, high systolic blood pressure, low handgrip strength, and multiple long-term conditions were significant mediators, and collectively explained 39.3% of their excess risk. The associations between these risk factors and COVID-19 mortality were stronger among older participants. Participants aged ≥75 without additional risk factors were at 4-fold risk (95% CI 1.57-9.96, P = 0.004) compared with all participants aged <65 years. Higher COVID-19 mortality among older adults was partially explained by other risk factors. 'Healthy' older adults were at much lower risk. Nonetheless, older age was an independent risk factor for COVID-19 mortality.

Identifiants

pubmed: 33152008
doi: 10.1371/journal.pone.0241824
pii: PONE-D-20-19014
pmc: PMC7644030
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0241824

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024774/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMJ. 2020 Feb 12;368:m131
pubmed: 32051121
JAMA. 2003 Jun 4;289(21):2801-9
pubmed: 12734147
Heart. 2015 Aug;101(15):1182-9
pubmed: 26041770
Lancet Infect Dis. 2009 Dec;9(12):737-46
pubmed: 19926034
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Geroscience. 2020 Jun;42(3):1013
pubmed: 32363428
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
BMJ. 1996 Sep 21;313(7059):711-5; discussion 715-6
pubmed: 8819439
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Am J Public Health. 2014 Nov;104(11):e118-25
pubmed: 25211746
Can Geriatr J. 2020 Mar 01;23(1):152-154
pubmed: 32550953
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
Circulation. 2020 Jul 7;142(1):4-6
pubmed: 32320270
BMJ. 2020 Mar 26;368:m1198
pubmed: 32217618
Epidemiol Infect. 2018 Nov 5;:1-5
pubmed: 30394248
Ageing Res Rev. 2011 Sep;10(4):430-9
pubmed: 21402176
Lancet Infect Dis. 2020 Apr;20(4):400-402
pubmed: 32113509
Oncotarget. 2015 Jan 30;6(3):1414-21
pubmed: 25638154
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Stat Med. 2013 Jun 15;32(13):2262-77
pubmed: 23034770
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Thorax. 1997 Sep;52(9):820-7
pubmed: 9371217
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Int J Tuberc Lung Dis. 2006 Dec;10(12):1399-405
pubmed: 17167959
Lancet. 2012 Mar 31;379(9822):1173-4
pubmed: 22463865

Auteurs

Frederick K Ho (FK)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Fanny Petermann-Rocha (F)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Stuart R Gray (SR)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Bhautesh D Jani (BD)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

S Vittal Katikireddi (SV)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Claire L Niedzwiedz (CL)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Hamish Foster (H)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Claire E Hastie (CE)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Daniel F Mackay (DF)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Jason M R Gill (JMR)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Catherine O'Donnell (C)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Paul Welsh (P)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Frances Mair (F)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Naveed Sattar (N)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Carlos A Celis-Morales (CA)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Jill P Pell (JP)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH